Evidence map›Paper›PMID 11571786›Full record

ArticleGlia2001

Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivo.

A Stiene-Martin, P E Knapp, K Martin, J A Gurwell, S Ryan, S R Thornton, F L Smith, K F Hauser

Open access · greenAbstract readComparative Study
In one paragraph

Article in Glia, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. An Investigation into Proteomic Constituents of Cerebrospinal Fluid in Patients with Chronic Peripheral Neuropathic Pain Medicated with Opioids- a Pilot Study.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2021
    Article
  16. Review
  17. Peripherally Acting Opioids in Orofacial Pain.Frontiers in neuroscience · 2021
    Review
  18. Article
  19. Opioid and neuroHIV Comorbidity - Current and Future Perspectives.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

A Stiene-MartinDepartment of Anatomy and Neurobiology, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
P E Knapp
K Martin
J A Gurwell
S Ryan
S R Thornton
F L Smith
K F Hauser
University of Kentucky · USVirginia Commonwealth University Medical Center · US

Funding

OPIOIDS AND CENTRAL NERVOUS SYSTEM VULNERABILITY TO HIVR01DA013559 · NIDA · UNIVERSITY OF KENTUCKY · PI HAUSER, KURT F · 2000 to 2004
$1.4M
NIDA NIH HHS DA 13559NIDA NIH HHS DA 40536NIDA NIH HHS R01 DA013559
6 · The paper itself

Abstract

Accumulating evidence, obtained largely in vitro, indicates that opioids regulate the genesis of neurons and glia and their precursors in the nervous system. Despite this evidence, few studies have assessed opioid receptor expression in identified cells within germinal zones or examined opioid effects on gliogenesis in vivo. To address this question, the role of opioids was explored in the subventricular zone (SVZ) and/or striatum of 2-5-day-old and/or adult ICR mice. The results showed that subpopulations of neurons, astrocytes, and oligodendrocytes in the SVZ and striatum differentially express mu-, delta-, and/or kappa-receptor immunoreactivity in a cell type-specific and developmentally regulated manner. In addition, DNA synthesis was assessed by examining 5-bromo-2'-deoxyuridine (BrdU) incorporation into glial and nonglial precursors. Morphine (a preferential mu-agonist) significantly decreased the number of BrdU-labeled GFAP(+) cells compared with controls or mice co-treated with naltrexone plus morphine. Alternatively, in S100beta(+) cells, morphine did not significantly decrease BrdU incorporation; however, significant differences were noted between mice treated with morphine and those treated with morphine plus naltrexone. Most cells were GFAP(-)/S100beta(-). When BrdU incorporation was assessed within the total population (glia and nonglia), morphine had no net effect, but naltrexone alone markedly increased BrdU incorporation. This finding suggests that DNA synthesis in GFAP(-)/S100beta(-) cells is tonically suppressed by endogenous opioids. Assuming that S100beta and GFAP, respectively, distinguish among younger and older astroglia, this implies that astroglial replication becomes increasingly sensitive to morphine during maturation, and suggests that opioids differentially regulate the development of distinct subpopulations of glia and glial precursors.

Indexed as

S100 ProteinsAgingAmino Acid Transport System X-AGAnimalsAnimals, NewbornAntigens, DifferentiationAntigens, SurfaceAstrocytesBromodeoxyuridineCalcium-Binding ProteinsCell DifferentiationCell DivisionGlial Fibrillary Acidic ProteinImmunohistochemistryLateral VentriclesMiceAmino Acid Transport System X-AGAntigens, DifferentiationAntigens, SurfaceBromodeoxyuridineCalcium-Binding ProteinsGlial Fibrillary Acidic ProteinMorphineNaltrexoneNerve Growth Factorsoligodendrocyte O antigen, mouseOpioid PeptidesReceptors, OpioidS100 Calcium Binding Protein beta SubunitS100 Proteins

Identifiers

PMID11571786
PMCPMC4303466
OpenAlexW2104569716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.